Millipore Hosts Analyst Meeting at the NYSE; CEO Madaus Rings The Opening Bell
Chairman, President and CEO Martin D. Madaus, Ph.D. Rings The Opening BellSMOn Wednesday, May 27, 2009, Billerica, Mass.-based Millipore Corporation hosted an analyst meeting at the New York Stock Exchange. Prior to the meeting, Chairman, President and CEO Martin D. Madaus, Ph.D. rang The Opening Bell, accompanied by Chief Financial Officer Charles Wagner; President of Bioscience Jonathan DiVincenzo; President of Bioprocess Jean-Paul Mangeolle; Corporate Communications Vice President Amanda Turton; and Investor Relations Director Joshua Young. A webcast of the event is available here.
Millipore, a leading provider of technologies, tools and services for the global life sciences industry, made formal presentations addressing the company’s markets, growth strategy, and financial performance and expectations. The meeting featured presentations from Chairman, President & CEO Martin Madaus; Chief Financial Officer Charles Wagner; President of the Bioscience Division Jonathan DiVincenzo; and President of the Bioprocess Division Jean-Paul Mangeolle.
An archived webcast of the analyst meeting is available here.
ABOUT MILLIPORE CORPORATION (NYSE: MIL):
Millipore is a life science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,000 employees in 47 countries worldwide. (Source: Millipore Corporation)
PHOTO/VIDEO:
Photos available via Associated Press/New York (212.621.1902), Reuters America (646.223.6285) and Bloomberg Photo (212.617.3420).

